Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleni Rebelos

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Diabetes, Obesity & Metabolism|February 24, 2021
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory studyJonas Oldgren, Sanna Laurila, Axel Åkerblom, et al.
Diabetes Research and Clinical Practice|May 10, 2026
Nephrin is produced in visceral adipose tissue in humans and associates with insulin resistanceEleni Rebelos, Chiara Rossi, Miikka-Juhani Honka, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 12, 2023
Insulin-stimulated brain glucose uptake correlates with brain metabolites in severe obesity: A combined neuroimaging studyEleni Rebelos, Aino Latva-Rasku, Kalle Koskensalo, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 22, 2021
Novel effects of the gastrointestinal hormone secretin on cardiac metabolism and renal functionSanna Laurila, Eleni Rebelos, Minna Lahesmaa, et al.
Diabetes Care|January 15, 2021
Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET CohortEleni Rebelos, Marco Bucci, Tomi Karjalainen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 18, 2026
Quantifying the individual disease duration-adjusted burden of complications in persons with type 2 diabetesLuca Sacchetta, Simone Gallo, Martina Chiriacò, et al.
Diabetes Care|June 28, 2024
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography StudyAino Latva-Rasku, Eleni Rebelos, Jouni Tuisku, et al.
World Journal of Hepatology|March 13, 2018
Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical researchMarcello Mancini, Paul Summers, Francesco Faita, et al.
Scientific Reports|July 7, 2022
Circulating N-Acetylaspartate does not track brain NAA concentrations, cognitive function or features of small vessel disease in humansEleni Rebelos, Giuseppe Daniele, Beatrice Campi, et al.
Diabetes, Obesity & Metabolism|July 22, 2025
Effects of reducing sedentary behaviour on renal glucose uptake during insulin stimulation: A post-hoc analysis of a 6-month randomized controlled trialEleni Rebelos, Prince Dadson, Tanja Sjöros, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Diabetes, Obesity & Metabolism|February 24, 2021
Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory studyJonas Oldgren, Sanna Laurila, Axel Åkerblom, et al.
Diabetes Research and Clinical Practice|May 10, 2026
Nephrin is produced in visceral adipose tissue in humans and associates with insulin resistanceEleni Rebelos, Chiara Rossi, Miikka-Juhani Honka, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 12, 2023
Insulin-stimulated brain glucose uptake correlates with brain metabolites in severe obesity: A combined neuroimaging studyEleni Rebelos, Aino Latva-Rasku, Kalle Koskensalo, et al.
American Journal of Physiology. Endocrinology and Metabolism|November 22, 2021
Novel effects of the gastrointestinal hormone secretin on cardiac metabolism and renal functionSanna Laurila, Eleni Rebelos, Minna Lahesmaa, et al.
Diabetes Care|January 15, 2021
Insulin Resistance Is Associated With Enhanced Brain Glucose Uptake During Euglycemic Hyperinsulinemia: A Large-Scale PET CohortEleni Rebelos, Marco Bucci, Tomi Karjalainen, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 18, 2026
Quantifying the individual disease duration-adjusted burden of complications in persons with type 2 diabetesLuca Sacchetta, Simone Gallo, Martina Chiriacò, et al.
Diabetes Care|June 28, 2024
SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography StudyAino Latva-Rasku, Eleni Rebelos, Jouni Tuisku, et al.
World Journal of Hepatology|March 13, 2018
Digital liver biopsy: Bio-imaging of fatty liver for translational and clinical researchMarcello Mancini, Paul Summers, Francesco Faita, et al.
Scientific Reports|July 7, 2022
Circulating N-Acetylaspartate does not track brain NAA concentrations, cognitive function or features of small vessel disease in humansEleni Rebelos, Giuseppe Daniele, Beatrice Campi, et al.
Diabetes, Obesity & Metabolism|July 22, 2025
Effects of reducing sedentary behaviour on renal glucose uptake during insulin stimulation: A post-hoc analysis of a 6-month randomized controlled trialEleni Rebelos, Prince Dadson, Tanja Sjöros, et al.
Pageof 9